Ultrasound Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Ultrasound Devices Market Trends and Insights

Increasing Incidences of Chronic Diseases

Cardiovascular, oncologic, and respiratory disorders account for most ultrasound referrals, making chronic-disease management a structural demand catalyst. An AI model for ovarian-tumor detection achieved an F1 score of 83.5%, surpassing expert radiologists. Similarly, deep-learning tools pinpoint the median nerve in carpal-tunnel scans with high accuracy. The American Cancer Society projects 2.04 million new cancer cases in the United States in 2025, up from 2.00 million in 2024, reinforcing long-term imaging demand. As AI accelerates workflow and elevates accuracy, it compensates for shortages of trained sonographers, broadening the user base and sustaining the ultrasound devices market.

Growing Minimally-Invasive Diagnostics and Imaging Facilities

A global pivot toward needle-guided biopsies, regional anesthesia, and musculoskeletal injections is deepening ultrasound’s procedural relevance. Fusion platforms that marry live ultrasound with CT, MRI, or PET scans are improving lesion targeting in complex cases. Facility growth reinforces the installed base: India counted 5,200 NABL-accredited labs in February 2024, 44% of which were radiology units.^{[1]National Accreditation Board for Testing and Calibration Laboratories, “Accredited Labs List,” nabl-india.org} Australia listed 4,462 accredited imaging practices by December 2023, 81% clustered in three populous states.^{[2]Australian Commission on Safety and Quality in Healthcare, “Accredited Imaging Practices 2024,” safetyandquality.gov.au} New centers such as ColumbiaDoctors/NY-Presbyterian’s Manhattan site opened in January 2025 to serve high-density urban catchments. This geographic spread of facilities feeds steady demand for both premium and mid-range ultrasound consoles, bolstering the ultrasound devices market.

Home-Based Pregnancy Monitoring Uptake

Handheld probes such as Vscan Air translate premium image quality into a cordless form factor, enabling prenatal scans outside hospitals. AI-embedded obstetric platformsexemplified by GE HealthCare’s Voluson series auto-measure fetal biometrics, shortening exam times while raising confidence. In underserved areas, early-risk detection via home scans triggers timely referrals and improves outcomes, a dynamic that broadens the ultrasound devices market beyond institutional boundaries.

Expansion of Tele-Ultrasound Networks

Cloud-connected software now streams live imaging feeds to specialists who guide novice operators in real time, reducing geographic barriers. Systems such as Philips Lumify with Reacts, Clarius Live and Butterfly iQ’s remote guidance gained traction during the COVID-19 public-health emergency. Research prototypes for robot-assisted ultrasound promise further reach once connectivity and reimbursement hurdles ease. These tele-consult platforms enlarge clinical reach without proportional capital outlays, reinforcing growth in the ultrasound devices market.

Limited Reimbursement for Hand-Held Scanners

Point-of-care ultrasound (POCUS) lacks dedicated billing codes for many primary-care indications. Fee-for-service models discourage broad deployment, constraining the ultrasound devices market in outpatient and home settings. Recent CMS proposals hint at progress, yet policy fragmentation across private payers persists, delaying return-on-investment for providers.

Strict Regulation for Approval

The U.S. FDA’s revised Quality-System Regulation, effective February 2026, harmonizes with ISO 13485 but raises short-term compliance costs. Concurrently, new pathways such as predetermined change-control plans streamline post-market tweaks. Device reclassification e.g., ultrasound cyclo destructive systems moving to class II reduces submission burdens. Outside the United States, India’s PCPNDT Act mandates strict center registration and record-keeping, circumscribing prenatal scan volumes. Collectively, these measures elongate time-to-market and elevate operating risk.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Application: Radiology Sustains Scale as Anesthesiology Accelerates

Radiology applications generated 23.12% of the ultrasound devices market revenue in 2025, fueled by multi-organ imaging needs. AI modules that flag ovarian malignancies now surpass human expertise, pushing hospitals to upgrade radiology workstations. Elastography refinements have also sharpened liver-fibrosis staging, widening non-invasive screening libraries.

Procedure-guided anesthesiology is fleetingly smaller but expanding at a 4.75% CAGR. Nerve-block adoption benefits from color-overlay aids such as ScanNav Anatomy PNB, which simplifies landmark recognition for trainees. Hospitals keen to cut anesthetic drug volumes and postoperative pain are buying specialized linear probes, scaling the ultrasound devices market in perioperative suites.

Growing hospital budgets for point-of-care scanners, together with national-level guidance encouraging opioid-sparing analgesia, will likely sustain double-digit equipment refresh rates in anesthesia departments. As AI curates preset imaging protocols, clinicians gain confidence to extend ultrasound-guided blocks beyond orthopedics into emergency and intensive-care environments. This cross-departmental spillover lifts utilization rates, reducing per-scan costs and reinforcing the economic case for investing in advanced platforms within the broader ultrasound devices market.

By Technology: 3D & 4D Imaging Holds Leadership, HIFU Builds Momentum

3D and 4D systems contributed 45.05% of the ultrasound devices market share in 2025. They are favored for obstetrics, pediatrics, and cardiology cases that need volumetric visualization. They are supported by machine-learning algorithms that auto-render fetal facial features in real time. Such automation frees clinicians to focus on counseling rather than knobology.

HIFU addresses niche but fast-scaling therapeutic areas from uterine fibroids to pancreatic tumors and is projected to grow at 4.98% CAGR. Academic trials indicate meaningful symptom relief with minimal recovery time, prompting payers in China and Europe to evaluate reimbursement frameworks. As surgical departments integrate HIFU into tumor boards, they diversify revenue streams while staying within radiology budgets, reinforcing the ultrasound devices market trajectory.

Integrated AI dashboards that quantify ablation zones instantaneously reduce intraoperative uncertainty. This precision complements oncology’s shift to outpatient day-care models, where rapid turnover and reduced infection risk are premiums. Consequently, technology vendors that meld high-frame-rate imaging with therapy beams will likely capture outsized share of incremental capital spending within the ultrasound devices market.

By Portability: Stationary Consoles Reign While Handheld Probes Surge

Hospital departments still favor cart-based consoles for their superior harmonics, dynamic-range depth, and integration with PACS; these units made up 69.10% of 2025 revenue. Yet purchasing committees are adding compact carts that dock tablets, bridging the stationary performance with mobility. A comparative study across six leading handheld devices crowned Vscan Air for usability and Lumify for superficial imaging. Such findings nudge clinicians to adopt portable probes for line placements and bedside lung assessments, expanding the ultrasound devices market.

Handhelds are forecast to compound at 7.88% annually, spurred by pricing that slips below USD 3,000 and subscription models bundling software updates. Wearable patches that capture continuous organ motion for 48 hours already show feasibility in cardiopulmonary monitoring.Once commercialization matures, these patches could redefine chronic-care protocols, representing the next disruption in the ultrasound devices market.

Manufacturers must balance ruggedness, battery longevity, and heat dissipation, especially in tropical climates. Cloud synchronization compliant with HIPAA and GDPR remains a design imperative as tele-ultrasound workflows proliferate. Firms that secure cybersecurity certifications will enjoy a trust premium, potentially tilting procurement decisions in favor of their offerings.

By End User: Hospitals Lead, Home-Care Expands Rapidly

Hospitals accounted for 54.62% of global spending in 2025, benefiting from multi-department utilization. The newest installations feature AI-powered preset optimization, as illustrated by Samsung Medison’s Z20 system for obstetrics. Hospitals also appreciate enterprise licensing that aligns ultrasound modalities with electronic medical records for seamless billing.

Home-care settings are projected to log the fastest 10.02% CAGR. Butterfly iQ3 combines a whole-body probe with automated measurements, aiding self-managed chronic-disease patients. Tele-ultrasound links connect nurses in community health centers to subspecialists, mitigating rural-care gaps. As reimbursement evolves from procedure-based to outcome-based models, payers acknowledge cost savings from early detection, further legitimizing at-home ultrasound pathways in the ultrasound devices market.

Digital-platform interoperability remains critical. Vendors offering software development kits for third-party integration with telehealth dashboards will likely capture disproportionate mindshare among home-health agencies. Education also matters: quick-start tutorials embedded in apps shorten learning curves, accelerating practitioner confidence and usage frequency.

Geography Analysis

North America retained a 37.85% revenue share in 2025 owing to strong payor coverage, a high chronic-disease burden, and steady technology refresh cycles. Launches such as Vave Health’s whole-body wireless device and GE HealthCare’s Automated Breast Ultrasound Premium illustrate the domestic appetite for AI-embedded innovation. Regulatory clarity and CPT codes for breast density screening underpin the quick onboarding of these solutions. Hospitals increasingly equip emergency departments with handheld probes, trimming triage times and improving bed flow, thus lifting the ultrasound devices market.

Asia-Pacific ranks as the fastest-growing region at a 4.66% CAGR. China dominates regional volume through procurement programs favoring domestically made consoles like Mindray’s Consona series. India’s “Make in India” ethos echoes through Wipro GE’s Versana Premier R3, an AI-ready system assembled in Bengaluru. Adoption of point-of-care ultrasound in overcrowded primary-care centers accelerates first-time purchases, though the PCPNDT Act restrains obstetric volumes. Nevertheless, public insurers increasingly reimburse liver and cardiac scans, sustaining the ultrasound devices market’s regional ascent.

Europe remains a technology-focused market. Agencies such as the European Medicines Agency require robust clinical data, prompting vendors to showcase evidence on dose-free imaging and interoperability with electronic health records. Focused-ultrasound milestones Insightec’s MRgFUS for essential tremor winning NUB status 1 reimbursement in Germany highlight innovation’s role in neurology and oncology insightec.com. WONCA Europe is rolling out structured ultrasound training for general practitioners, widening the community-care footprint. Collectively, these dynamics keep Europe a vital contributor to the ultrasound devices market.

Regulatory Landscape

Regulatory requirements are tightening around quality systems, software change management, and device traceability, which is increasing compliance workloads for ultrasound OEMs and their supply chains. In the United States, the FDA has guidance for marketing clearance of diagnostic ultrasound systems and transducers, and the revised Quality System Regulation becomes effective in February 2026, aligning quality management expectations more closely with ISO 13485 and reinforcing design controls, validation, and post-market processes for both cart-based and handheld platforms.

In Europe, MDR implementation continues to shape technical documentation, Notified Body capacity planning, and nomenclature alignment. Updated MDCG guidance released in April 2026 on classification, EMDN assignment, and borderline determinations adds another layer of documentation discipline, and the European Commission mandates specific EUDAMED transition modules (including Actor, UDI/Device, Notified Body certificates, and Market Surveillance) from May 2026. In China, NMPA and CMDE are reinforcing standards and review depth, including a 2026 industry standards revisions plan affecting medical device standards, and an April 2026 registration review guideline for intravascular ultrasound (IVUS) diagnostic systems and catheters that treats IVUS as Class III, raising evidence and technical-file expectations for specialized ultrasound modalities.

Market Opportunities and Future Outlook

Near-term opportunity is concentrated in software-defined upgrades and regulatory-enabled refresh cycles that convert installed base demand into recurring workflow and automation adoption. In June 2026, the FDA finalized a Class II (special controls) classification for real-time ultrasound anatomy visualization and labeling devices under 21 CFR 892.1550, supporting a 510(k) pathway that reduces friction for commercialization of guidance and labeling capabilities embedded into ultrasound workflows. The report context also points to multiple 2026 clearances for AI and automation layers, including Philips Elevate Plus for EPIQ Elite and Affiniti (FDA 510(k) clearance, June 2026), indicating that differentiation is increasingly delivered through software packages, structured reporting, and cloud-connected review rather than hardware alone.

Decentralized care is a workable whitespace for handheld and compact systems, but monetization depends on training, governance, and reimbursement mechanics rather than device availability alone. The report context also highlights persistent reimbursement gaps for handheld scanners in the United States, while tele-ultrasound platforms, such as Philips Lumify with Reacts, have already demonstrated remote guidance workflows that extend use beyond radiology departments. Public programs and localization initiatives in Asia-Pacific, including China procurement preferences and India-focused manufacturing and assembly activity, support broader access and first-time purchases, particularly where facility footprints and accredited imaging capacity are expanding. Vendors that combine handheld adoption with standardized protocols, cybersecurity-compliant cloud synchronization, and enterprise integration are positioned to capture more value from point-of-care expansion.